VSee Health, Inc. (NASDAQ:VSEE) Short Interest Up 344.2% in July

VSee Health, Inc. (NASDAQ:VSEE) was the recipient of a large increase in short interest in the month of July. As of July 31st, there was short interest totaling 7,318,494 shares, an increase of 344.2% from the July 15th total of 1,647,591 shares. Based on an average daily volume of 21,913,840 shares, the short-interest ratio is currently 0.3 days. Currently, 203.3% of the company’s stock are short sold.

VSee Health Stock Down 6.2%

NASDAQ VSEE traded down $0.00 on Friday, reaching $0.03. The company had a trading volume of 247,721 shares, compared to its average volume of 4,141,735. The company has a debt-to-equity ratio of 0.12, a current ratio of 0.41 and a quick ratio of 0.41. VSee Health has a 1 year low of $0.01 and a 1 year high of $2.52. The firm has a 50-day moving average of $0.10 and a 200-day moving average of $0.20. The firm has a market capitalization of $97,920.00 and a PE ratio of -0.05.

VSee Health (NASDAQ:VSEE) last posted its quarterly earnings data on Friday, May 15th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.06. The company had revenue of $3.16 million for the quarter, compared to analyst estimates of $4.80 million. VSee Health had a negative net margin of 92.36% and a negative return on equity of 11,636.34%.

Hedge Funds Weigh In On VSee Health

An institutional investor recently bought a new position in VSee Health stock. Virtu Financial LLC acquired a new stake in VSee Health, Inc. (NASDAQ:VSEE) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 66,489 shares of the company’s stock, valued at approximately $25,000. 1.01% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of VSee Health in a research report on Friday, July 17th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

About VSee Health

VSee Health is a telehealth technology company that develops secure, HIPAA-compliant software solutions for virtual care. The company’s flagship platform offers high-definition video visits, real-time messaging and collaboration tools designed to streamline remote consultations between patients and healthcare providers. VSee’s solutions are built to integrate with electronic health record systems and include features such as digital waiting rooms, screen sharing and file transfer capabilities.

In addition to video conferencing, VSee Health provides remote patient monitoring (RPM) tools that enable clinicians to collect biometric data, such as blood pressure, heart rate and glucose readings, from patients in their homes.